Bispecific Antibody Combinations for Optimized Anti-Tumor Activity in Liquid & Solid Tumors
Time: 4:15 pm
day: Day 1
Details:
- Co-localizing “signal 1” (TCR) and “signal 2” (co-stimulation) within the tumor microenvironment to drive optimized anti-tumor responses
- Integrating signal 3 (cytokine support) for even deeper anti-tumor responses
- Preclinical and clinical data support rational combinations with biologics in patients
